Results 11 to 20 of about 23,559,862 (313)

Cetuximab and biomarkers in non-small-cell lung carcinoma

open access: yesBiologics: Targets & Therapy, 2012
Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer ...
Patil N, Abba M, Allgayer H
doaj   +6 more sources

Diagnostic Utility of TTF-1 and P40 Immunohistochemical Markers for Subtyping of Non-Small Cell Lung Carcinoma

open access: yesJournal of Medical Sciences and Health, 2023
Background : Lung cancer is the leading cause of cancer-related mortality over worldwide. Although the pathological diagnosis of lung carcinoma is limited as only small specimen available for diagnosis, the availability of targeted therapies has
Mayank Agrawal   +4 more
doaj   +1 more source

The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study [PDF]

open access: yesZagazig University Medical Journal, 2019
Background: Malignant pleural mesothelioma (MPM) and non-small cell lung carcinoma (NSCLC) are common diseases with rising incidence, patients have different prognosis and are treated differently, and thus it is very important to diagnose these ...
Amira Salem   +3 more
doaj   +1 more source

the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma

open access: yesمجلة كلية الطب, 2023
Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet   +3 more
doaj   +1 more source

Severe hyponatremia due to paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in non-small cell lung carcinoma transforming to small cell lung carcinoma during treatment with immune checkpoint inhibitor

open access: yesCurrent Problems in Cancer: Case Reports, 2021
This is the first case described of transformation from EGFR wild-type non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) during immunotherapy presenting with severe hyponatremia due to paraneoplastic syndrome of inappropriate ...
Vicky Mai   +4 more
doaj   +1 more source

Durable response to durvalumab‐based immunochemotherapy in small‐cell lung carcinoma transformation from EGFR‐mutant non–small cell lung cancer: A case report

open access: yesThoracic Cancer, 2022
Combined small‐cell lung carcinoma (C‐SCLC) is small‐cell lung carcinoma (SCLC) with added non–small‐cell morphology. We report a case of epidermal growth factor receptor (EGFR) mutation‐positive C‐SCLC in an 84‐year‐old patient with metastatic brain ...
Yu‐Chung Li
doaj   +1 more source

Lung: Non-small cell carcinoma [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Non-small cell carcinomas are divided into three main categories according to the predominant morphology of the tumour cells as determined by light microscopy. Although it is possible to distinguish different histological sub-groups in this way, or by using gene expression profiling, treatment is currently decided on the basis of tumour staging, age ...
J Heighway, DC Betticher
openaire   +1 more source

Dramatic response to pembrolizumab with chemotherapy followed by salvage surgery in a lung cancer patient

open access: yesThoracic Cancer, 2021
Immune checkpoint inhibitors with chemotherapy have been shown to exhibit remarkable efficacy for advanced non‐small‐cell lung carcinoma and are under investigation as an induction therapy.
Shunichi Saito   +6 more
doaj   +1 more source

Epigenetics in non-small cell lung carcinomas

open access: yesSalud Pública de México, 2019
Objective. To perform a systematic review of the main epi­genetic aberrations involved in non-small cell lung carcinomas’ (NSCLC) diagnosis, progression, and therapeutics. Materials and methods. We performed a systematic review of the scientific literature on lung cancer epigenetics, focusing on NSCLC. Results.
Irlanda Peralta-Arrieta   +3 more
openaire   +3 more sources

Non-small cell lung carcinoma metastasis to the anus [PDF]

open access: yesBMJ Case Reports, 2016
A 70-year-old man presenting with a lung mass was investigated and treated with pneumonectomy for adenocarcinoma of the lung. He re-presented 3 months later with a large perianal abscess and mass. Subsequent investigations and biopsies showed disseminated metastases from the lung primary.
Ramya Gowri, Dhandapani   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy